Thursday - March 28, 2024
Achillion Pharmaceuticals Assigned Patent for Substituted Aliphanes
Copyright © Targeted News Service, 2017
2017-12-09
ALEXANDRIA, Va., Dec. 9 -- Achillion Pharmaceuticals, New Haven, Connecticut, has been assigned a patent (9,833,440) developed by nine co-inventors for "substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections." The co-inventors are Jason Allan Wiles, Hamden, Connecticut, Qiuping Wang, Bethany, Connecticut, Akihiro Hashimoto, Branford, Connecticut, Godwin Pais, Hamden, Connecticut, Xiangzhu Wang, Madison, Connecticut, . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information or a free trial

Copyright Targeted News Service 2017